AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death.
Getinge inks $320M Healthmark takeover to bolster US sterile reprocessing capabilities
Dive Brief: Getinge has paid $320 million to acquire Healthmark Industries for its U.S. sterile reprocessing capabilities. Healthmark makes instrument care and infection control consumables
October 12, 2023